These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Patents and patients: the implications of the Prometheus v. Mayo Supreme Court decision. Rasheed N MLO Med Lab Obs; 2012 Jul; 44(7):60-1. PubMed ID: 22852222 [No Abstract] [Full Text] [Related]
63. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Teitelbaum R; Cohen M Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990 [No Abstract] [Full Text] [Related]
64. Testing time for gene patents. Nature; 2010 Apr; 464(7291):957. PubMed ID: 20393513 [No Abstract] [Full Text] [Related]
65. Patents. Signature on visitor's form fuels Stanford v. Roche court battle. Marshall E Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725 [No Abstract] [Full Text] [Related]
68. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
69. Supreme Court to decide whether payments by patent holders to delay production of generics are anticompetitive. Roehr B BMJ; 2012 Dec; 345():e8464. PubMed ID: 23236054 [No Abstract] [Full Text] [Related]
70. Welcome to the genomic era. Guttmacher AE; Collins FS N Engl J Med; 2003 Sep; 349(10):996-8. PubMed ID: 12954750 [No Abstract] [Full Text] [Related]
71. Patenting Laws of Nature: Effect on Cardiovascular Innovation. Boumil MM; Curfman G JAMA Cardiol; 2018 Nov; 3(11):1031-1032. PubMed ID: 30347007 [No Abstract] [Full Text] [Related]
73. Medical-process patents--monopolizing the delivery of health care. Kesselheim AS; Mello MM N Engl J Med; 2006 Nov; 355(19):2036-41. PubMed ID: 17093256 [No Abstract] [Full Text] [Related]
74. Test based on natural processes cannot be patented, rules US court. Dyer C BMJ; 2012 Mar; 344():e2290. PubMed ID: 22446741 [No Abstract] [Full Text] [Related]
75. On gene patenting. Healy B N Engl J Med; 1992 Aug; 327(9):664-8. PubMed ID: 1640972 [No Abstract] [Full Text] [Related]
76. Intellectual property. Biotech feels a chill from changing U.S. patent rules. Servick K Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626 [No Abstract] [Full Text] [Related]
77. Patents on breast cancer genes are illegal and stymie research, say scientists. Lenzer J BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010 [No Abstract] [Full Text] [Related]
78. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? Chandrasekharan S; McGuire AL; Van den Veyver IB Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832 [TBL] [Abstract][Full Text] [Related]
79. DNA patent decision leaves questions for diagnostics. Harrison C Nat Rev Drug Discov; 2011 Aug; 10(9):650-1. PubMed ID: 21878971 [No Abstract] [Full Text] [Related]
80. The Supremes got it right. Somberg J Am J Ther; 2013; 20(4):315. PubMed ID: 23838630 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]